Recent Articles from TheStreet

Novavax Lead

Novavax Stock Surges on Covid-19 Vaccine Application to WHO

Novavax and Serum Institute of India have applied to the WHO for an emergency use listing of Novavax's Covid-19 vaccine.

Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take

Rite Aid Stock Must Hold This Key Support Level After Dip on Earnings

Rite Aid stock has one key support level left before more potential downside. Investors trading the stock should keep that level in mind.

Cannabis Weed Marijuana Federal Lead

U.S. Cannabis Stocks Rise on Effort to Allow Bank Financing

Measure to allow banks to finance the cannabis industry passes voice vote in U.S. House.

Wall Street Lead

Dow Climbs On Fed Tapering Stance; Evergrande Debt In Focus

Stocks surge amid the Fed's patience on tapering and amid cautious optimism for a brokered solution to the Evergrande debt crisis.

Joby Aviation Lead

Air Taxi Maker Joby Aviation Rated Overweight by Morgan Stanley

Joby is 'a first mover to address the urban air mobility market,' which Morgan Stanley sees at $1 trillion in 2040 and $9 trillion in 2050.

Get Excited About Roku: Streaming Content Is Starting to Get Very Interesting

Roku Lifted to Buy; Guggenheim Sees Growth Overseas, Ad Potential

Guggenheim raised Roku to a buy based on the streaming-tech company's growth potential overseas and more potent advertising capabilities.

Nouriel Roubini Lead

Roubini Sees Overheated Growth, Then Rampant Stagflation

'The rosy scenario that is currently priced into financial markets may turn out to be a pipe dream,' says the famously bearish economist Nouriel Roubini.